• Explore /
  • Poster
  • / Real-world assessment of changing treatment patterns and sequence for patients with metastatic renal cell carcinoma (mRCC) in the first-line (1L) setting.

Real-world assessment of changing treatment patterns and sequence for patients with metastatic renal cell carcinoma (mRCC) in the first-line (1L) setting.

Abstract Poster

Authors

null

Neil J. Shah

Memorial Sloan Kettering Cancer Center, New York, NY

Neil J. Shah , Sneha Sura , Reshma Shinde , Junxin Shi , Rodolfo F. Perini , Singhal Puneet , Nicholas J. Robert , Nicholas J. Vogelzang , Robert J. Motzer

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2022 ASCO Genitourinary Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session C: Renal Cell Cancer; Adrenal, Penile, Urethral, and Testicular Cancers

Track

Renal Cell Cancer,Adrenal Cancer,Penile Cancer,Testicular Cancer,Urethral Cancer

Sub Track

Quality of Care/Quality Improvement and Real-World Evidence

Citation

J Clin Oncol 40, 2022 (suppl 6; abstr 302)

DOI

10.1200/JCO.2022.40.6_suppl.302

Abstract #

302

Poster Bd #

D7

Abstract Disclosures

Similar Posters

First Author: Daniel M. Geynisman

First Author: Neil J. Shah

First Author: Connor Wells

First Author: Mehul Gupta